Leader Healthcare and EpiGuard Partner Up for Qatar & the United Arab Emirates

EpiGuard reports a new agreement will make more isolation stretchers, the so called EpiShuttle, available to citizens and visitors of Qatar and the UAE.

The distributer agreement was signed by the frontrunner of medical equipment in the Middle East, Leader Healthcare, and the cutting-edge technology developer EpiGuard. The two firms are now set on improving the preparedness of Qatar and the United Arab Emirates.

We have been searching for the best product to isolate and transport contaminated or contagious individuals. In our search, we found the EpiShuttle to have unparalleled features. The EpiShuttle is by far the superior product on the market. At the same time, it is the most cost efficient in use, Malaz M. Fadlallah, Head of Medical Division of Leader Healthcare said.

The EpiShuttle by EpiGuard is a single-patient isolation and transport system, designed to provide maximum public safety while allowing critical care and treatment to be performed on the contaminated patient inside.

– The EpiShuttle represents a major step forward in public safety, especially when it comes to large-scale mass gatherings. Large religious gatherings and sports events represent significant challenges for the entire health sector of host countries. Today, emerging and increasing public threats of natural or deliberate nature significantly increase the health and safety vulnerability of mass gatherings. The EpiShuttle has already proven effective in live transports of patients contaminated with chemical war agents as well as in hundreds of Covid-19 transports. We have also seen the EpiShuttle provide safe and efficient transports of patients with other infectious diseases like Ebola and Tuberculosis, Ellen Cathrine Andersen, CEO of EpiGuard said.

– We found a very good partner in Leader Healthcare. They have provided the finest healthcare solutions for more than ten years, and the EpiShuttle is a good strategic fit with their competence and knowledge. Now, we hope the EpiShuttle can keep even more citizens in Qatar and the UAE, safe from both existing threats and, perhaps more importantly so-far unknown threats, in years to come, Andersen continued.

– The EpiShuttle protects the surroundings from any contaminated person, while at the same time it allows for monitoring and full intensive care treatment of the unfortunate one inside. In addition, the adjustable backrest of the EpiShuttle is extremely important when trying to keep coughing from patients with yet unseen variants of Covid-19, at a minimum, Sukhdeep Sachdev, The Global CEO of Leader Healthcare explained.

– The EpiShuttle is a single patient isolation and transport system, for safe and certified transport of contagious patients through air, land, and sea. The EpiShuttle makes everyone safer, especially when we do not know what will strike next, the EpiShuttle is the safe choice, Andersen said.

The EpiShuttle is designed to protect both the environment or a single individual from contamination, in either positive or negative air-pressure mode. It can isolate and save a VIP, out of a contaminated area, in positive air-pressure mode.

The EpiShuttle is already in use with Abu Dhabi Police and Dubai Corporation for Ambulance Services. Qatar, however, has no EpiShuttles.

On a global scale, the EpiShuttle is used by WHO as well as first responders in Germany, Belgium, Denmark, Peru, Ireland, Greece, Norway, and Finland. Also, national air forces like the British, Australian, Canadian, Danish, Norwegian and others are equipped with EpiShuttles. In the pirate sector you find EpiShuttles with companies Like FAI air ambulance, Air Alliance Medflight, DRF Luftrettung, Keewatin Air, Luxembourg Air Rescue, Loganair and others.

SourceEpiGuard

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”